ReviewCurrent cancer drug targets2024

Elucidating the Role of Pro-renin Receptors in Pancreatic Ductal Adenocarcinoma Progression: A Novel Therapeutic Target in Cancer Therapy.

Mohsen Aliakbarian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.